Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Deferred Taxes (2016 - 2025)

Altimmune (ALT) has disclosed Deferred Taxes for 8 consecutive years, with -$681000.0 as the latest value for Q1 2025.

  • On a quarterly basis, Deferred Taxes changed N/A to -$681000.0 in Q1 2025 year-over-year; TTM through Sep 2025 was -$681000.0, a N/A change, with the full-year FY2019 number at $58500.0, up 100.95% from a year prior.
  • Deferred Taxes was -$681000.0 for Q1 2025 at Altimmune, up from -$9.2 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of -$681000.0 in Q1 2025 to a low of -$681000.0 in Q1 2025.